Dr. Robert S. Muhumuza, MD

Dr. Muhumuza practices at Rapides Regional Medical Center in Alexandria, Louisiana, part of HCA Healthcare.

Dr. Muhumuza's NPI, 1073524591, was assigned on August 10, 2006. Dr. Muhumuza holds Louisiana license 11701R.

Dr. Muhumuza's primary practice is Rapides Regional Medical Center, at 211 4th Street, Alexandria, LA 71301 in Rapides Parish. The practice phone is (318) 769-3000.

Dr. Muhumuza's primary practice is Rapides Regional Medical Center in Alexandria, Louisiana, part of HCA Healthcare. Dr. Muhumuza is also affiliated with Ochsner Medical Center - Baton Rouge. The medical group on file is The Digestive Group. Dmand AI also links Dr. Muhumuza to 2 more hospitals, 3 group practices and clinics, 3 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muhumuza practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Muhumuza's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Muhumuza is licensed in Louisiana.

CMS data shows 585 Medicare services from Dr. Muhumuza across 14 procedure codes in 2024, for 279 Medicare patients. Medicare paid $61,333 for them.

CMS counts 279 Medicare patients who saw Dr. Muhumuza in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muhumuza's median patient age at 65, with 57% women.

In 2024, Dr. Muhumuza wrote 29 Medicare Part D claims for 11 patients. 93% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $2,694 in total drug cost. In 2021, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Muhumuza for performance year 2024, reported as part of a group. Dr. Muhumuza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 252 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Muhumuza, more than 93% of the clinicians it reports for that procedure.

CMS Open Payments shows 316 general payments to Dr. Muhumuza from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Merck Sharp & Dohme Corporation paid the most, $2,272.